Pharmacology of serotonin: what a clinician should know | Gut
Re-evaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data - ScienceDirect
Clinical Pharmacokinetics of Tegaserod, a Serotonin 5-HT4 Receptor Partial Agonist with Promotile Activity | SpringerLink
Emerging pharmacological therapies for IBS and mechanisms of action.... | Download Scientific Diagram
Receptor binding profile of 5-HT 4 agonists for GI disorders, at... | Download Table
Frontiers | Tegaserod Maleate Inhibits Esophageal Squamous Cell Carcinoma Proliferation by Suppressing the Peroxisome Pathway | Oncology
Frontiers | Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents | Pharmacology
Constipation: understanding mechanisms and management. | Semantic Scholar
Tegaserod | C16H23N5O - PubChem
Linaclotide: pharmacology and clinical perspective LINACLOTIDE: PHARMACOLOGY AND CLINICAL PERSPECTIVE INTRODUCTION In developed countries, between 10 and 20% of the population suffers from Irritable Bowel Syndrome or Chronic ...
Re-evaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data - ScienceDirect
Tegaserod - Wikipedia
Frontiers | Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents | Pharmacology
Linaclotide: pharmacology and clinical perspective LINACLOTIDE: PHARMACOLOGY AND CLINICAL PERSPECTIVE INTRODUCTION In developed countries, between 10 and 20% of the population suffers from Irritable Bowel Syndrome or Chronic ...
Systematic Review: FDA-Approved Prescription Medications for Adults With Constipation. - Abstract - Europe PMC
Tegaserod - Wikipedia
Figure 1 from TREATMENT OF IRRITABLE BOWEL SYNDROME — NEW APPROACHES , SERIES # 5 Drug Treatment of IBS with Serotonin ( 5-HT ) Modulators | Semantic Scholar